James Mackay is a distinguished scientist and business leader in the life sciences sector, currently serving as the Co-Founder, President, and CEO of Crystalys Therapeutics Inc. They have a strong record of bringing multiple drugs to market, notably achieving FDA and EMA approval for Zurampic and leading a $1.2 billion acquisition of Ardea Biosciences into AstraZeneca. With experience managing both large pharmaceutical and small biotech companies, James emphasizes strategic communication, partnership development, and cultivating a positive organizational culture. They are also an independent board member for several companies and actively contribute to initiatives aimed at addressing social challenges within the San Diego community. James earned a First Class degree from the University of Aberdeen.
This person is not in the org chart
This person is not in any teams
This person is not in any offices